Last $238.61 USD
Change Today +3.53 / 1.50%
Volume 1.2M
SHPG On Other Exchanges
Symbol
Exchange
SHPG is not on other exchanges.
As of 8:10 PM 07/10/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Flemming Ornskov M.D., MBA, MPH

Chief Executive Officer, Managing Director and Director, Shire plc
AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 1 different industries.

See Board Relationships
56$3,402,000
As of Fiscal Year 2013

Background*

Dr. Flemming Ornskov, M.D., MBA, MPH has been the Chief Executive Officer of Shire plc since April 30, 2013 and serves as its Managing Director. Dr. Ornskov served as Head of Human Genetic Therapies at Shire plc since March 31, 2013. Dr. Ornskov served as the Chief Marketing Officer and Global Head of Strategic Marketing for General & Specialty Medicine at Bayer from 2010 to 2012. Prior to joining Bayer, Dr. Ornskov served as Global President, Pharmaceuticals and OTC ...

Read Full Background

Corporate Headquarters*

5 Riverwalk
Dublin, Co. Dublin 24

Ireland

Phone: 353 1 429 7700
Fax: --

Board Members Memberships*

2013-Present
Chief Executive Officer, Managing Director and Director

Education*

MBA
INSEAD
MPH
Harvard University
MD
Københavns Universitet

Other Affiliations*

Annual Compensation*

Salary$1,071,000
Bonus$1,600,000
Total Annual Compensation$2,671,000

Stock Options*

All Other Compensation$731,000

Total Compensation*

Total Annual Cash Compensation$3,402,000
Total Short Term Compensation$2,671,000
Other Long Term Compensation$731,000
Total Calculated Compensation$3,402,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SHPG:US $238.61 USD +3.53

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Actavis plc
--
David E. I. Pyott Chairman and Chief Executive Officer
Allergan Inc.
$1.4M
Robert J. Hugin MBAChairman, Chief Executive Officer, President and Chairman of Executive Committee
Celgene Corporation
$1.3M
J. Michael Pearson Chairman and Chief Executive Officer
Valeant Pharmaceuticals International, Inc.
$1.8M
Paul R. Perreault BA PsychologyChief Executive Officer, Managing Director, Executive Director and Member of Innovation & Development Committee
CSL Ltd.
$1.9M
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHIRE PLC-ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.